What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s unrealized gains on investments?

Over 3 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s unrealized gains on investments has grown at a 118.7% compound annual growth rate (CAGR), from $84K to $879K.

Madrigal Pharmaceuticals, Inc. MDGL Unrealized Gains on Investments

Unrealized Gains on Investments at other companies

LPL Financial HoldingsLPLA

$31.28M+97.4%

BKBK

$232M-13.4%

Bank of AmericaBAC

$118M+3.5%

Chimera Investment Corp.CIM

$58.26M+112%

Wintrust FinancialWTFC

$6.17M+17.5%

General Purpose Acquisition Corp. GPAC

$5.6K-47.9%

Other financials

Income statement

See full

Revenue$311.3M+127%

Gross profit$43.5M—

Operating income-$92.7M-16.9%

Net income-$94.4M-28.9%

EPS (diluted)-$3.25-24.5%

Balance sheet

See full

Cash & equivalents$232.2M+23.1%

Total debt$377.3M+187%

Total equity$543.5M-23.5%

Total assets$1.2B+23.1%

Cash flow

See full

Operating cash flow-$167.4M-88.4%

CapEx$3.8M—

Free cash flow-$171.3M-92.7%

Valuation

See full

Market cap$11.66B+64.2%

Enterprise value$11.81B+67.5%

P/S10.3×-12.1×

Profitability

See full

Gross margin96.5%—

Operating margin-27.7%-12.2pp

Net margin-27.3%-12.0pp

FCF margin-59.8%-29.6pp

Returns & leverage

See full

Return on equity-49.3%-0.8pp

Debt / equity0.7×+0.5×

Current ratio3.5×-2.4×

Where this comes from

Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Madrigal Pharmaceuticals, Inc.'s unrealized gains on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Madrigal Pharmaceuticals, Inc.'s unrealized gains on investments?: Madrigal Pharmaceuticals, Inc. (MDGL) reported unrealized gains on investments of $155K in Q1 2026.
How has Madrigal Pharmaceuticals, Inc.'s unrealized gains on investments changed year-over-year?: Madrigal Pharmaceuticals, Inc.'s unrealized gains on investments decreased by 64.4% year-over-year, from $435K to $155K.
What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s unrealized gains on investments?: Over 3 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s unrealized gains on investments has grown at a 118.7% compound annual growth rate (CAGR), from $84K to $879K.